Researchers shed light on shrinking of chromosomesJune 12, 2007A human cell contains an enormous 1.8 metres of DNA partitioned into 46 chromosomes. These have to be copied and distributed equally into two daughter cells at every division. Condensation, the shortening of chromosomes, allows the cell to handle such huge amounts of genetic material during cell division and helps preventing fatal defects in chromosome separation. Now researchers from the European Molecular Biology Laboratory [EMBL] for the first time tracked chromosome condensation in mammalian cells over the entire course of cell division. In this week's advanced online publication of Nature Cell Biology they report crucial new insights into timing, function and molecular basis of chromosome condensation. What happens when chromosomes are not correctly separated and distributed during cell division we know very well; two daughter cells with either broken chromosomes or different numbers of chromosomes result and severe diseases including cancer can arise. But so far we know only little about condensation, a process crucial to the successful separation of chromosomes. Using powerful microscopes, researchers led by Jan Ellenberg at EMBL looked at living mammalian cells to find out how and when chromosomes shorten during cell division. Condensation begins early, when the cell starts preparing for division, and the chromosomes become shorter and shorter until they are about to separate and migrate towards the poles of the cell. "It is at this stage that textbooks say chromosomes are shortest. Then, after separating they would expand again," says Ellenberg. "But we found something very different. Shortly after they finish separating, chromosomes actually condense even further. This makes sense, because in this way they are shortest when the physical division of one cell body into two takes place. Like this, no long chromosome arms extend over the plane of division, because that could expose the DNA to serious mechanical damage." The extreme condensation of chromosomes towards the end of cell division can also serve as a safety net if something goes wrong with chromosome separation in earlier phases of division. When the researchers added chemicals to the cell to block the late condensation, more separation defects appeared. "Sometimes chromosomes get stuck and cannot be fully separated by the spindle that normally distributes them into the daughter cells," says Felipe Mora-Bermúdez, who carried out the experiments in Ellenberg's lab, "we think that the 'super condensation' at later stages helps to disentangle such chromosomes and acts as a back-up mechanism to rescue separation defects." The EMBL researchers found that an enzyme called Aurora kinase is crucially involved in this process. Blocking this enzyme abolishes late condensation of chromosomes. They now hope to uncover the detailed molecular mechanism underlying the late shortening of chromosomes. This could further advance our understanding of cell division and the risk factors that lead to defects in chromosome separation and their dramatic consequences. European Molecular Biology Laboratory [EMBL] |
|||||||||||||||||||||
| Related Chromosomes Current Events and Chromosomes News Articles NIH-funded researchers transform embryonic stem cells into human germ cells Researchers funded in part by the National Institutes of Health have discovered how to transform human embryonic stem cells into germ cells, the embryonic cells that ultimately give rise to sperm and eggs. A solution to Darwin's 'mystery of the mysteries' emerges from the dark matter of the genome Biological species are often defined on the basis of reproductive isolation. Ever since Darwin pointed out his difficulty in explaining why crosses between two species often yield sterile or inviable progeny (for instance, mules emerging from a cross between a horse and a donkey), biologists have struggled with this question. Common weed could provide clues on aging and cancer A common weed and human cancer cells could provide some very uncommon details about DNA structure and its relationship with telomeres and how they affect cellular aging and cancer, according to a team led by scientists from Texas A&M University and the University of Cincinnati (UC). CSHL-led team discovers rare mutation dramatically increasing schizophrenia risk An international team of researchers led by geneticist Jonathan Sebat, Ph.D., of Cold Spring Harbor Laboratory (CSHL), has identified a mutation on human chromosome 16 that substantially increases risk for schizophrenia. Standards for a new genomic era A team of geneticists at Los Alamos National Laboratory, together with a consortium of international researchers, has recently proposed a set of standards designed to elucidate the quality of publicly available genetic sequencing information. New chromosomal abnormality identified in leukemia associated with Down syndrome Researchers identified a new chromosomal abnormality in acute lymphoblastic leukemia (ALL) that appears to work in concert with another mutation to give rise to cancer. This latest anomaly is particularly common in children with Down syndrome. Mice regain ability to extend telomeres suggesting potential for dyskeratosis congenita therapy The human genetic disease dyskeratosis congenita (DKC) is an autosomal dominant disease that leads to abnormalities in tissues with a rapid cell turnover - the skin, nails, bone marrow, lungs and gut. National Science Foundation congratulates Nobel Laureates in medicine/physiology, chemistry and economics The National Science Foundation (NSF) congratulates the 2009 Nobel laureates, particularly those who have received NSF funding over the years: Jack W. Szostak, who shared the prize in physiology or medicine; Thomas A. Steitz, who shared the prize in chemistry; and Elinor Ostrom and Oliver E. Williamson who earned the Sveriges Riksbank Prize in economic sciences in memory of Alfred Nobel 2009. Genome-wide study of autism published in Nature In one of the first studies of its kind, an international team of researchers has uncovered a single-letter change in the genetic code that is associated with autism. New treatment more than doubles survival for high risk childhood leukemia Results of a phase two clinical trial published October 5th in the Journal of Clinical Oncology show that adding continuous daily doses of a targeted drug called imatinib mesylate to regular chemotherapy more than doubled three-year survival rates for children with a high risk type of blood cancer called Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). More Chromosomes Current Events and Chromosomes News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||